JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

Search

Smith & Nephew PLC ADR

Geschlossen

31.94 -2.44

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

31.74

Max

32.75

Schlüsselkennzahlen

By Trading Economics

Einkommen

35M

331M

Verkäufe

203M

3.2B

KGV

Branchendurchschnitt

23.923

60.328

Dividendenrendite

2.29

Gewinnspanne

10.368

Angestellte

16,988

EBITDA

133M

856M

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

+6.9% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

2.29%

2.24%

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-578M

15B

Vorheriger Eröffnungskurs

34.38

Vorheriger Schlusskurs

31.94

Technischer Score

By Trading Central

Vertrauen

Bullish Evidence

Smith & Nephew PLC ADR Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

24. Apr. 2026, 00:00 UTC

Ergebnisse

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

24. Apr. 2026, 00:00 UTC

Ergebnisse

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

23. Apr. 2026, 23:47 UTC

Market Talk

Gold Edges Lower Amid Ongoing Concerns Over Higher Inflation -- Market Talk

23. Apr. 2026, 23:43 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23. Apr. 2026, 23:43 UTC

Market Talk

Global Equities Roundup: Market Talk

23. Apr. 2026, 23:43 UTC

Market Talk

Nikkei May Decline Amid Uncertainty Over U.S.-Iran Conflict -- Market Talk

23. Apr. 2026, 23:13 UTC

Akquisitionen, Fusionen, Übernahmen

Trump on Spirit Airlines: 'I Think We'd Just Buy It' -- Update

23. Apr. 2026, 22:33 UTC

Ergebnisse

Intel Shares Jump 20% as AI Agents Drive Big Growth -- WSJ

23. Apr. 2026, 22:17 UTC

Ergebnisse

PLS Executed Offtake Agreement With Ronbay

23. Apr. 2026, 22:17 UTC

Ergebnisse

PLS Secured Up to A$38.1M in Australia Government ARENA Grant Funding

23. Apr. 2026, 22:16 UTC

Ergebnisse

PLS Commences Commissioning of Midstream Demonstration Plant

23. Apr. 2026, 22:15 UTC

Ergebnisse

PLS Group Reaffirms FY26 Guidance for All Metrics

23. Apr. 2026, 22:14 UTC

Ergebnisse

PLS Group 3Q Cash Margin From Operations A$461M at March 31

23. Apr. 2026, 22:14 UTC

Ergebnisse

PLS Group 3Q Cash Balance A$1.455 Billion at March 31

23. Apr. 2026, 22:13 UTC

Ergebnisse

PLS Group 3Q Unit Operating Cost A$733/Ton CIF, Up 2% on 2Q

23. Apr. 2026, 22:12 UTC

Ergebnisse

Correct: PLS Group 3Q Unit Operating Cost A$520/Ton FOB, Down 11% on 2Q

23. Apr. 2026, 22:12 UTC

Ergebnisse

PLS Group 3Q Unit Operating Cost US$520/Ton FOB, Down 11% on 2Q

23. Apr. 2026, 22:11 UTC

Ergebnisse

PLS Group 3Q Realized Price US$1,867/Ton, Up 61% on 2Q

23. Apr. 2026, 22:10 UTC

Ergebnisse

PLS Group 3Q Revenue A$567,000, Up 52% on 2Q

23. Apr. 2026, 22:09 UTC

Ergebnisse

PLS Group 3Q Sales 195,700 Tons, Down 16% on 2Q

23. Apr. 2026, 22:08 UTC

Ergebnisse

PLS Group 3Q Production 232,400 Tons, Up 12% on 2Q

23. Apr. 2026, 22:04 UTC

Ergebnisse

Intel Sales Rise 7% as AI Agents Drive Growth -- WSJ

23. Apr. 2026, 21:56 UTC

Market Talk
Ergebnisse

Intel Points to Growing Role of CPUs Amid AI Shifts -- Market Talk

23. Apr. 2026, 21:48 UTC

Akquisitionen, Fusionen, Übernahmen

Regeneron Shares Up on Trump Drug Pricing Deal -- Barrons.com

23. Apr. 2026, 21:27 UTC

Ergebnisse

Intel CFO: All Demand Signals Point to Growing Role of CPUs in AI Era

23. Apr. 2026, 21:25 UTC

Ergebnisse

Intel CFO Expects Factories to Continue Increasing Supply in 3Q, 4Q, but at More Measured Pace Than Previously Expected

23. Apr. 2026, 21:24 UTC

Ergebnisse

SAP Stock Rebounds From Software Slaughter. The Cloud Boosted Europe's Tech Titan. -- Barrons.com

23. Apr. 2026, 21:24 UTC

Ergebnisse

Blackstone Stock Falls After Earnings. Private Credit Remains in Focus. -- Barrons.com

23. Apr. 2026, 21:21 UTC

Ergebnisse

Intel to Look for Unconventional Way to Boost Manufacturing Capacity Through Musk's Terafab Project, CEO Says

23. Apr. 2026, 21:21 UTC

Ergebnisse

Intel CEO: He, Elon Musk Believe Global Semiconductor Supply Isn't Keeping Up With Accelerating Demand

Peer-Vergleich

Kursveränderung

Smith & Nephew PLC ADR Prognose

Kursziel

By TipRanks

6.9% Vorteil

12-Monats-Prognose

Durchschnitt 35 USD  6.9%

Hoch 35 USD

Tief 35 USD

Basierend auf 1 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Smith & Nephew PLC ADR – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

1 ratings

0

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

26.64 / 28.37Unterstützung & Widerstand

Kurzfristig

Bullish Evidence

Mittelfristig

Bullish Evidence

Langfristig

Bullish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat